Medigene AG Financials

Medigene Stock Summary

Medigene competes with Northwest Biotherapeutics, Geron, Qrons, and Processa Pharmaceuticals. Medigene AG, a biotechnology company, focuses on the development of T cell immunotherapies for the treatment of cancer. The company was founded in 1994 and is headquartered in Munich, Germany. Medigene operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 61 people.

Medigene Key Financial Ratios

There are many critical financial ratios that Medigene's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Medigene AG reports annually and quarterly.

Medigene Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Medigene's current stock value. Our valuation model uses many indicators to compare Medigene value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medigene competition to find correlations between indicators driving Medigene's intrinsic value. More Info.Medigene AG is regarded fourth in return on equity category among its peers. It is considered to be number one stock in return on asset category among its peers reporting about  0.50  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Medigene AG is roughly  1.99 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medigene's earnings, one of the primary drivers of an investment's value.

Medigene Market Pulse

Along with financial statement analysis, the daily predictive indicators of Medigene help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Medigene AG. We use our internally-developed statistical techniques to arrive at the intrinsic value of Medigene AG based on widely used predictive technical indicators. In general, we focus on analyzing Medigene Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Medigene's daily price indicators and compare them against related drivers.

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

If you are still planning to invest in Medigene AG check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medigene's history and understand the potential risks before investing.